First Patient Included in Multicenter Study to Evaluate SIRS-Lab’s Dia
- ICU
- 05/04/2011
SIRS-Lab, a molecular diagnostics company based in Jena, Germany, announced the inclusion of the first patient in a 1000-patient clinical study evaluating their molecular pathogen test VYOO. The...
READ MORE